Tag: CIRSE

Experts discuss latest results from EFFPAC and TINTIN trials presented at...

NOTE: ONLY intended for healthcare professionals outside of the USA. Ulf Teichgräber (Jena, Germany) and Koen Deloose (Dendermonde, Belgium) discuss the 24-month results of the...
curriculum

CIRSE updates and expands their interventional radiology curriculum for medical students

The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) has released a newly revised interventional radiology (IR) curriculum for medical students. Where the original...
CIRSE

CIRSE updates position on paclitaxel use in peripheral arteries

The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) has released a statement on the use of paclitaxel-coated balloons and stents in the treatment...
Stem cell

Stem cell therapy is the future of critical limb ischaemia management

Addressing the audience at the 33rd annual meeting of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE; 22–25 September, Lisbon, Portugal), Sanjiv Sharma...

Leading interventional radiology societies call for expanded stroke training

In a joint, global position statement, the Society of Interventional Radiology (SIR), Cardiovascular and Interventional Radiology Society of Europe (CIRSE) and the Interventional Radiology...
coil

A “mediocre success rate” found for coil embolization to obtain intrahepatic...

Coil embolization of hepatic arteries to induce redistribution of blood flow and microspheres has a mediocre success rate, concluded a recent study presented by...

Lessons from randomised controlled trials utilising SIRT in liver cancer

A recent session at CIRSE 2018 sought to go beyond the headline findings from a number of recent randomised controlled trials (RCTs) in interventional...
Lutonix

Interim results of the Lutonix drug-coated balloon in a complex patient...

This article is sponsored by BD. In a complex patient population with advanced, symptomatic below-the-knee peripheral artery disease, treatment with the Lutonix drug-coated balloon (BD)...
covered

Covered stent provides greater patency than angioplasty alone in AV fistulae

The Covera vascular covered stent (BD) has a superior six-month primary patency rate than standard balloon angioplasty, with an equivalent safety at 30 days,...

Real-time imaging: Ultrasound detects a biodegradable embolic microsphere after prostatic artery...

Researchers report the use of ultrasound to detect embolization in real time for patients undergoing treatment for benign prostatic hyperplasia (BPH). Richard Owen (University...

Eluvia outperforms Zilver PTX in IMPERIAL 12-month results

The Eluvia drug-eluting vascular stent system (Boston Scientific) shows superior primary patency compared to the Zilver PTX drug-eluting stent (Cook Medical), concludes the 12-month...
ICEfx

ICEfx cryoablation system launches globally at CIRSE 2018

BTG has announced the global launch of its ICEfx cryoablation system. This is an evolution of the existing Visual ICE system, and according to...

First patient enrolled in CIREL, a Europe-wide observational study on TACE...

The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) announced that the first patient has been enrolled in CIREL (CIRSE registry for LifePearl microspheres),...

Cook Medical’s inferior vena cava filters fare better than ALN’s in...

Gerard Goh, Radiology, The Alfred Hospital, Melbourne, Australia, reported results from a comparative study of inferior vena cava (IVC) filters at CIRSE 2017 that...

Eluvia paclitaxel-eluting stent shows long-term freedom from revascularisation at three years

Boston Scientific has announced the three-year results from the MAJESTIC trial for the Eluvia paclitaxel-eluting vascular stent system at the Cardiovascular and Interventional Radiological...
QuiremSpheres

Terumo launches QuiremSpheres microspheres in Europe

Terumo has announced that it has launched QuiremSpheres microspheres in Europe on 18 September. QuiremSpheres, the next generation of selective internal radiation therapy (SIRT) microspheres...

Luminor DCB shows high clinical effectiveness in six-month EffPAC data

The six-month results from the full clinical cohort of the EffPAC randomised study were presented in the drug-coated balloon (DCB) abstracts session at the...

Guerbet announces CE mark for Vectorio mixing and injection system for...

Guerbet has announced obtaining the CE mark for its conventional transarterial chemoembolization (cTACE) mixing and injection system, Vectorio. Designed in collaboration with interventional radiologists worldwide,...

CIRSE launches new journal—CVIR Endovascular

Cardiovascular and Interventional Radiological Society of Europe (CIRSE) has announced the start of a new journal, CVIR Endovascular, which will be an offshoot of...

Mentice aims to reduce TACE procedure times and radiation exposure with...

Mentice has announced the release of a new simulation training software for transarterial chemoembolization (TACE). The new software was showcased at the 2017 CIRSE...

Update for CIRSE’s European IR Curriculum and Syllabus

The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) has announced the presentation of the second edition of the European Curriculum and Syllabus for...

CIRA appoints Daniel Lapointe as new executive director

The Canadian Interventional Radiology Association (CIRA) Board of Directors has announced the appointment of Daniel Lapointe as CIRA’s new executive director on the association’s...

CIRSE launches Europe-wide study of transarterial chemoembolization with Terumo Lifepearl

  The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) has launched its CIRSE Registry for LifePearl Microspheres (CIREL), a new European-wide observational study that...

The ESR and CIRSE join forces to promote patient care

The European Society of Radiology (ESR) and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE), have joined forces to address the future of...

Irreversible electroporation has “potential to become new standard of care” in...

A new study presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE 2016, 10–14 September, Barcelona, Spain) meeting finds that the treatment...